Pennsylvania HR 358: A Resolution recognizing November 1, 2025, as "Tylenol Day" in Pennsylvania.
Status: Referred to Health (as of 2025-10-27)
State: Pennsylvania · Session: 2025-2026 · Bill: HR 358
Sponsors: Greg Scott, Benjamin Sanchez, Gina Curry, Kristine Howard, Malcolm Kenyatta, Mary Jo Daley, Nancy Guenst
Bill Text
PRINTER'S NO. 2527 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE RESOLUTION No. 358 Session of 2025 INTRODUCED BY SCOTT, DALEY, SANCHEZ, HOWARD, KENYATTA AND GUENST, OCTOBER 24, 2025 REFERRED TO COMMITTEE ON HEALTH, OCTOBER 27, 2025 A RESOLUTION Recognizing November 1, 2025, as "Tylenol Day" in Pennsylvania. WHEREAS, In 1884, two German physicians prescribed naphthalene to a patient they were treating for worms and a fever; and WHEREAS, The naphthalene did not relieve the patient's worms, but it did reduce the patient's fever, an effect that was not previously known; and WHEREAS, The physicians learned that the pharmacy had made a mistake and provided acetanilide, a compound isolated from coal tar; and WHEREAS, The physicians worked with a pharmaceutical firm to investigate the effects of acetanilide and confirmed that it reduced fever; and WHEREAS, After acetanilide was marketed as Antifebrin, users reported bluish skin after taking it; and WHEREAS, The cause of the bluish skin was identified as methemoglobinemia, a condition in which the oxygen transported 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 by hemoglobin is impaired; and WHEREAS, These findings led researchers to seek safer alternatives by altering the molecular structure of compounds to eliminate side effects; and WHEREAS, In 1887, a German company known as Bayer modified acetanilide to produce phenacetin, which did not cause methemoglobinemia; and WHEREAS, Later in 1887, a physician and a chemist worked together to find another derivative of acetanilide, now known as acetaminophen; and WHEREAS, The founders of acetaminophen recommended an extensive investigation into the medication before it became available to the public; and WHEREAS, The effectiveness and safety of acetaminophen as a fever and pain reliever were not confirmed until 1949, based on modern research techniques and clinical use in England; and WHEREAS, Because phenacetin was linked to kidney problems and aspirin to stomach problems, acetaminophen was promoted as the safer medication; and WHEREAS, In the late 1940s, McNeil Laboratories, a Philadelphia family-owned business, began studying the safety and efficacy of acetaminophen in hopes of marketing it for a future product; and WHEREAS, McNeil Laboratories began as a family-run pharmacy and later expanded into the manufacturing of prescription medicines; and WHEREAS, In 1955, McNeil Laboratories introduced Tylenol Elixir for Children after receiving approval by the United States Food and Drug Administration (FDA); and WHEREAS, Tylenol Elixir for Children was the first single- 20250HR0358PN2527 - 2 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ingredient acetaminophen product on the market and was available only by prescription; and WHEREAS, In 1959, Johnson & Johnson acquired McNeil Laboratories; and WHEREAS, In 1959, Tylenol was approved for sale without a prescription, leading to its availability over the counter the following year; and WHEREAS, Tylenol has become the best-known product of the more than 600 products on the market that contain the active ingredient acetaminophen; and WHEREAS, Tylenol has more than two dozen products in various forms, including liquids, dissolvable powders, chewable tablets, caplets and capsules; and WHEREAS, Each Tylenol product is formulated for different symptoms, age groups and delivery methods; and WHEREAS, Tylenol offers products for pain and fever relief, as well as for arthritis, cold and flu symptoms, sinus relief and sleep; and WHEREAS, It is estimated that nearly 25% of adults in the United States use a medication containing acetaminophen each week; and WHEREAS, Tylenol is the number one doctor-recommended pain reliever brand; and WHEREAS, The year 2025 commemorates the 70th anniversary of Tylenol receiving FDA approval and being introduced by McNeil Laboratories; therefore be it RESOLVED, That the House of Representatives recognize November 1, 2025, as "Tylenol Day" in Pennsylvania. 20250HR0358PN2527 - 3 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
View Pennsylvania HR 358 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.